Epilepsy Society professor wins 2016 Excellence in Epilepsy Award
Epilepsy Society's Professor Philip Patsalos has been awarded the 2016 Excellence in Epilepsy Award by the British Chapter of the International League Against Epilepsy. The accolade is for lifetime achievement in the field of epilepsy.
Professor Patsalos is head of the charity's Therapeutic Drug Monitoring (TDM) Unit at the Chalfont Centre in Buckinghamshire, where he has worked for 34 years. He is also professor of clinical pharmacology at the Institute of Neurology-University College London.
New anti-epileptic drugs
The award recognises his commitment to the pioneering studies of new anti-epileptic drugs and the implementation of therapeutic drug monitoring in the UK and many other countries around the world. His work has been critical in ensuring that several high risk groups in epilepsy - children, pregnant women and the elderly - are prescribed the dose of anti-epileptic drugs that will give them optimum seizure control and minimum side effects.
John Paul Leach, president of the ILAE British Chapter said: "It is always difficult to pick out the outstanding performers in the epilepsy community, but Professor Patsalos made this a relatively easy choice this year.
"His landmark and groundbreaking studies have been absolutely pivotal in allowing the adoption of the newer anti-epileptic drugs introduced since the 1990s. He is held in such warm and high regard and the ILAE council recognise that he is a particularly fitting recipient of this year's award."
Therapeutic drug monitoring
Professor Patsalos said: "I am delighted to receive this prestigious award. However, I need to thank and recognise my many colleagues, collaborators and indeed students who I have worked with over the years and who have been very much a part of all that we have achieved in the field of anti-epileptic drug therapeutics and therapeutic drug monitoring."
Medical director at Epilepsy Society, Ley Sander paid tribute to Professor Patsalos: "This award is richly deserved. Philip has greatly influenced the way we treat people with uncontrolled seizures.
"As a colleague he is unfailingly supportive, reliable and courteous, always going the extra mile regardless of pressures of work. His legacy is an unrivalled knowledge base of the complete armamentarium of anti-epileptic drugs and the potential for safer, more accurate prescribing of drugs for people worldwide with epilepsy."
The TDM Unit is the only centre in the UK to measure drug concentrations for all licensed anti-epileptic drugs. Last year it was awarded accreditation by the UK Accreditation Service (UKAS) for the second year in a row.
Find out more about Epilepsy Society's Therapeutic Drug Monitoring unit.
Share this article: